Advent Technologies (ADN) Reports Q1 Loss of $0.23

Advent Technologies (NASDAQ: ADN) reported Q1 EPS of ($0.23). Revenue for the quarter came in at $1 million..

For earnings history and earnings-related data on Advent Technologies (ADN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c